Heron Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.08 | -$0.07 | -$0.07 |
| Q2 2024 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2024 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2024 | 2 | -$0.04 | -$0.02 | -$0.03 |
Heron Therapeutics, Inc. Earnings Date And Information
Heron Therapeutics, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.06 earnings per share for the quarter, missing analysts' consensus estimates of $-0.04 by $0.02. The company had revenue of 42.27 M for the quarter and had revenue of 127.04 M for the year. Heron Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.8 diluted earnings per share) and currently has a price-to-earnings ratio of -6.78. Heron Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Heron Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.03 | $36.77 M | $42.27 M | ||
| 08/06/2024 | Q2 2024 | -$0.04 | -$0.06 | -0.02 | $36.09 M | $36.02 M |
| 05/07/2024 | Q1 2024 | -$0.08 | -$0.02 | 0.06 | $34.67 M | |
| 03/12/2024 | Q4 2023 | -$0.15 | -$0.07 | 0.08 | $34.23 M | |
| 09/29/2023 | Q3 2023 | -$0.17 | $32.65 M | $31.43 M | ||
| 08/14/2023 | Q2 2023 | -$0.23 | -$0.35 | -0.12 | $31.70 M | $31.76 M |
| 05/11/2023 | Q1 2023 | -$0.17 | -$0.27 | -0.1 | $29.62 M | |
| 03/29/2023 | Q4 2022 | -$0.23 | $30.03 M | |||
| 11/08/2022 | Q3 2022 | -$0.39 | -$0.38 | 0.01 | $26.96 M | $26.56 M |
| 08/09/2022 | Q2 2022 | -$0.50 | -$0.62 | -0.12 | $24.55 M | $27.63 M |
| 05/09/2022 | Q1 2022 | -$0.45 | -$0.64 | -0.19 | $23.46 M | |
| 02/28/2022 | Q4 2021 | -$0.59 | -$0.54 | 0.05 | $20.66 M | |
| 11/03/2021 | Q3 2021 | -$0.60 | -$0.51 | 0.09 | $25.52 M | $23.23 M |
| 08/09/2021 | Q2 2021 | -$0.59 | -$0.62 | -0.03 | $29.45 M | $22.44 M |
| 05/10/2021 | Q1 2021 | -$0.57 | -$0.58 | -0.01 | $20.02 M | |
| 02/24/2021 | Q4 2020 | -$0.68 | -$0.68 | 0 | $20.61 M | |
| 11/05/2020 | Q3 2020 | -$0.65 | -$0.64 | 0.01 | $17.17 M | $19.97 M |
| 08/05/2020 | Q2 2020 | -$0.59 | -$0.61 | -0.02 | $19.81 M | $22.67 M |
| 05/06/2020 | Q1 2020 | -$0.63 | -$0.57 | 0.06 | $25.40 M | |
| 03/02/2020 | Q4 2019 | -$0.58 | -$0.65 | -0.07 | $35.08 M |
Heron Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Heron Therapeutics, Inc.'s earnings date?
Heron Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Heron Therapeutics, Inc.'s earnings conference call?
The conference call for Heron Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Heron Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Heron Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Heron Therapeutics, Inc. generate each year?
Heron Therapeutics, Inc. (:HRTX) has a recorded annual revenue of $127.04 M.
-
How much profit does Heron Therapeutics, Inc. generate each year?
Heron Therapeutics, Inc. (:HRTX) has a recorded net income of $127.04 M. Heron Therapeutics, Inc. has generated $-0.8 earnings per share over the last four quarters.
-
What is Heron Therapeutics, Inc.'s price-to-earnings ratio?
Heron Therapeutics, Inc. (:HRTX) has a price-to-earnings ratio of -6.78 and price/earnings-to-growth ratio is -0.15.
